This collaboration aligns with our goal to develop multiple treatments and modalities for #obesity and #cardiometabolic disease to help address critical gaps in patient care, writes Chris Boshoff, Chief Scientific Officer, Pfizer, on LinkedIn
In the past year, many telehealth and digital health companies, including Hims & Hers competitor Ro, have jumped into the market, offering prescriptions for GLP-1s as part of an existing weight loss or chronic condition management program or creating a new service line targeting obesity care
Among these herbal products are Ginkgo biloba extract (GbE) and L-carnitine (Salama et al
In 2025, the largest pharma and healthcare employers span continents and sectors from traditional drug manufacturing and biotech innovation to retail pharmacy and clinical services
Read the full article: #MayoClinic #HeartTransplant #GLP1 #PatientOutcomes D